Earlier this week, the FDA approved a groundbreaking new drug for advanced pancreatic cancer. Agency officials announced it gave the pill, daraxonrasib, approval more than six months ahead of a target date. Dr. Omer Awan, a senior public health contributor for Forbes, joins "NewsNation Live" to discuss the landmark medication. #pancreaticcancer #drug #fda Get a fast-paced look at the latest from the border to Main Street to the White House on "NewsNation Live." Weekends starting at 10a/9C Saturdays and 11a/10C Sundays. #NewsNationLive NewsNation is your source for fact-based, unbiased news for all Americans.
Former Nebraska Senator Ben Sasse, given three to four months to live after a Stage 4 pancreatic cancer diagnosis last December, says his tumors have shrunk by more than 80%, and he's using his borrowed time to sound the alarm on China, failing schools, and a coming technological upheaval. Sasse, 54, shared the health update […] The post Ben Sasse offers striking cancer update — and a blunt warning about where America is headed appeared first on American Almanac .
Former Nebraska Senator Ben Sasse, given three to four months to live after a Stage 4 pancreatic cancer diagnosis last December, says his tumors have shrunk by more than 80%, and he's using his borrowed time to sound the alarm on China, failing schools, and a coming technological upheaval. Sasse, 54, shared the health update and his outlook on the country's future in a pre-recorded interview for the Western Conservative Summit in Lakewood, Colorado, held on the campus of Colorado Christian University. Fox News Digital obtained the interview exclusively. Nearly seven months after doctors told him he had weeks left, Sasse is still here, and still swinging. He credited a clinical trial drug called daraxonrasib, an oral therapy designed to…Open
Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have more reason to hope than ever before.
Daraxonrasib is in clinical trials, but drugmaker Revolution Medicines says it increases overall survival rates of metastatic pancreatic cancer. NewsNation’s Rich Bodee has the details on the new drug.
